ストックスクリーナーアプリを入手
37.69
0.37%
-0.14
プレマーケット:
37.69
前日終値:
$37.83
開ける：
$38.09
24時間の取引高:
1.83M
Relative Volume:
0.78
時価総額：
$5.71B
収益：
$3.24B
当期純損益:
$304.90M
株価収益率:
18.12
EPS:
2.08
ネットキャッシュフロー:
$156.70M
1週間 パフォーマンス:
+1.15%
1か月 パフォーマンス:
-7.46%
6か月 パフォーマンス:
-35.55%
1年 パフォーマンス:
-40.71%
1日の値動き範囲:
$37.42
$38.24
1週間の範囲:
$35.73
$38.50
52週間の値動き範囲:
$34.10
$72.94
Bruker Corp Stock (BRKR) Company Profile
BRKR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
37.69 | 5.65B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
133.94 | 231.14B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.83 | 154.60B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
383.10 | 146.12B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
87.00 | 105.64B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.77 | 45.60B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-19 | 開始されました | Guggenheim | Buy |
| 2024-12-10 | 開始されました | UBS | Neutral |
| 2024-12-05 | アップグレード | Goldman | Sell → Neutral |
| 2024-10-15 | 開始されました | Barclays | Overweight |
| 2024-09-30 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-02-14 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2022-10-21 | 開始されました | UBS | Buy |
| 2022-08-22 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-06-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2021-02-05 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | 開始されました | Goldman | Sell |
| 2020-11-16 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | ダウングレード | Cleveland Research | Buy → Neutral |
| 2020-04-02 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | ダウングレード | Needham | Strong Buy → Hold |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-01-08 | 開始されました | Wells Fargo | Overweight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-09-26 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | アップグレード | Goldman | Sell → Neutral |
| 2019-06-24 | 繰り返されました | Needham | Strong Buy |
| 2019-06-21 | 繰り返されました | BofA/Merrill | Neutral |
| 2019-05-30 | 開始されました | Wolfe Research | Peer Perform |
| 2019-05-06 | 繰り返されました | Needham | Strong Buy |
| 2019-05-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | アップグレード | UBS | Sell → Neutral |
| 2019-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2019-02-12 | 繰り返されました | BTIG Research | Buy |
| 2019-01-03 | 開始されました | Needham | Strong Buy |
すべてを表示
Bruker Corp (BRKR) 最新ニュース
Bruker introduces new timsUltra AIP System at ASMS 2025 - SelectScience
Bruker at Jefferies Conference: Strategic Growth Amid Challenges - Investing.com
biocrates life sciences ag becomes part of Bruker Group - SelectScience
Bruker launches revolutionary timsOmni mass spectrometer at ASMS 2025 - SelectScience
New proteoElute nanoLC System and PepSep Advanced nLC Columns showcased at ASMS 2025 - SelectScience
Bruker Applied MS Unveils Strategic Innovations at ASMS 2025, Showcasing Advances in DART Technology for TDM and DoA Analysis and Launching timsMetabo™ for PFAS and Environmental Contaminant Detection - Quantisnow
Bruker Corporation (BRKR) Acquires Biocrates to Expand Multiomics Solutions - Insider Monkey
Bruker invests in diagnostics, unveils new analysis platform By Investing.com - Investing.com Nigeria
Should You Invest in Bruker Corp (BRKR)? - Insider Monkey
Bruker (BRKR) Acquires Biocrates to Boost Metabolomics Solutions - GuruFocus
Bruker expands multiomics with biocrates acquisition - Investing.com
Bruker (BRKR) Expands with Biocrates Life Sciences Acquisition | BRKR Stock News - GuruFocus
Bruker Announces Acquisition of biocrates, a Leader in Mass Spectrometry-based Quantitative Metabolomics - Quantisnow
Bruker unveils new mass spectrometer with enhanced sensitivity By Investing.com - Investing.com South Africa
Bruker (BRKR) Unveils Advanced Mass Spectrometer for 4D-Proteomics | BRKR Stock News - GuruFocus
Bruker (BRKR) Unveils Advanced Proteomics System at Industry Conference | BRKR Stock News - GuruFocus
Bruker Launches New timsUltra AIP System with Further Enhanced, Extreme Sensitivity for Single-Cell Proteomics, FNA Biopsy Immunopeptidomics and Metaproteomics – Company AnnouncementFT.com - Financial Times
Bruker Unveils New proteoElute™ nanoLC System and PepSep® Advanced nLC Columns for up to 50% Improved Peptide Sensitivity - Seeking Alpha
Bruker introduces novel timsMetabo mass spectrometer introduced at ASMS 2025 - SelectScience
Zacks Research Has Optimistic Outlook of Bruker Q4 Earnings - Defense World
Bruker Leadership to Share Strategic Insights at Major Jefferies Healthcare Conference Next Week - Stock Titan
Bruker (BRKR) Introduces Advanced Mass Spectrometry System | BRK - GuruFocus
Bruker launches timsOmni system for advanced proteomics - Investing.com
Revolutionary timsOmni Mass Spectrometer Transforms Protein Research and Drug Development - Stock Titan
Bruker (BRKR) Unveils Advanced 4D-Metabolomics System | BRKR Stock News - GuruFocus
Zacks Research Has Pessimistic Outlook of Bruker Q2 Earnings - Defense World
Bruker unveils new timsMetabo system for metabolomics - Investing.com
Bruker Launches Novel timsMetabo™ Mass Spectrometer for Breakthrough 4D-Metabolomics and 4D-Lipidomics Sensitivity, Specificity and Annotation Confidenceat Speed, Depth, and Scale - Yahoo Finance
Bruker Stock to Gain From the Launch of MOVE-T Liquid Dairy Analyzer - Yahoo Finance
Bruker launches MOVE-T for dairy quality control By Investing.com - Investing.com South Africa
Bruker Corp: Pan-Omics Dominance At A Margin Inflection Point (BRKR) - Seeking Alpha
Bruker launches MOVE-T for dairy quality control - Investing.com
Bruker Introduces Novel MOVE-T System for Transferable, Robust Milk and Liquid Dairy Analysis with FT-NIR Technology - Quantisnow
Bruker Corp (BRKR) Shares Up 4.51% on May 27 - GuruFocus
Deutsche Bank AG Has $865,000 Position in Bruker Co. (NASDAQ:BRKR) - Defense World
Bruker (BRKR) Downgraded by Citigroup with Price Target Lowered to $40 | BRKR Stock News - GuruFocus
Expert Outlook: Bruker Through The Eyes Of 8 Analysts - Benzinga
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Benzinga
Citi cuts Bruker stock rating, lowers price target to $40 - Investing.com
Bruker (BRKR) Downgraded to Neutral by Citi with $40 Price Target | BRKR Stock News - GuruFocus
Bruker Corp (BRKR) Shares Down 3.3% on May 21 - GuruFocus
Benchtop Optofluidic System | Bruker Nano Surfaces | Products - Photonics Spectra
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stock News - GuruFocus
Bruker (BRKR) Shows Positive Signals Post-Settlement | BRKR Stoc - GuruFocus
July 18th Options Now Available For Bruker (BRKR) - Nasdaq
Bruker (BRKR) and 10x Genomics Resolve Global Patent Dispute | B - GuruFocus
Bruker (BRKR) and 10x Genomics Settle Patent Disputes Globally - GuruFocus
Bruker Sets Next Dividend Payment: $0.05 Per Share Coming June 27Key Dates Inside - Stock Titan
10x Genomics settles patent dispute with Bruker for $68 million By Investing.com - Investing.com Canada
10x Genomics settles patent dispute with Bruker for $68 million - Investing.com
10x Genomics Announces Patent Litigation Settlement Agreement with Bruker - Financial Times
Bruker Corp (BRKR) 財務データ
収益
当期純利益
現金流量
EPS
Bruker Corp (BRKR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| LINTON WILLIAM A | Director |
Apr 22 '25 |
Option Exercise |
24.00 |
10,000 |
240,000 |
58,723 |
| Bures Thomas | Chief Accounting Officer |
Mar 10 '25 |
Buy |
47.40 |
500 |
23,698 |
3,472 |
| LAUKIEN FRANK H | PRESIDENT & CEO |
Feb 18 '25 |
Buy |
50.92 |
20,000 |
1,018,330 |
38,459,563 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Option Exercise |
19.12 |
10,000 |
191,200 |
84,254 |
| PACKER RICHARD A | Director |
Dec 02 '24 |
Sale |
57.82 |
3,350 |
193,683 |
80,904 |
0.64%
0.61%
大文字化:
|
ボリューム (24 時間):